U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C10H14N4O3
Molecular Weight 238.2432
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PROXYPHYLLINE

SMILES

CC(O)CN1C=NC2=C1C(=O)N(C)C(=O)N2C

InChI

InChIKey=KYHQZNGJUGFTGR-UHFFFAOYSA-N
InChI=1S/C10H14N4O3/c1-6(15)4-14-5-11-8-7(14)9(16)13(3)10(17)12(8)2/h5-6,15H,4H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C10H14N4O3
Molecular Weight 238.2432
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description
Curator's Comment: description was created based on several sources, including http://www.ndrugs.com/?s=ephedrine/proxyphylline

Proxyphylline is a xanthine derivative that acts as a cardiac stimulant, vasodilator and bronchodilator. In combination with ephedrine it’s used for relief of acute bronchial asthma and for reversible bronchospasm associated with chronic bronchitis and emphysema. Proxyphylline is readily absorbed from the gastrointestinal tract and it’s not converted to theophylline in the body. The clinical studies are agreed with the property of proxyphylline to inhibit the cyclic nucleotide phosphodiesterases.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Secondary
Novofilin

Approved Use

Unknown
Secondary
Unknown

Approved Use

Unknown
Secondary
Unknown

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
6.87 mg/L
300 mg single, oral
dose: 300 mg
route of administration: Oral
experiment type: SINGLE
co-administered: DYPHYLLINE
PROXYPHYLLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
3.946 μg/mL
150 mg single, oral
dose: 150 mg
route of administration: Oral
experiment type: SINGLE
co-administered: EPHEDRINE HYDROCHLORIDE
PROXYPHYLLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
3.588 μg/mL
150 mg single, oral
dose: 150 mg
route of administration: Oral
experiment type: SINGLE
co-administered: EPHEDRINE HYDROCHLORIDE
PROXYPHYLLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
59.57 μg × h/mL
150 mg single, oral
dose: 150 mg
route of administration: Oral
experiment type: SINGLE
co-administered: EPHEDRINE HYDROCHLORIDE
PROXYPHYLLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
46.38 μg × h/mL
150 mg single, oral
dose: 150 mg
route of administration: Oral
experiment type: SINGLE
co-administered: EPHEDRINE HYDROCHLORIDE
PROXYPHYLLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
8.69 h
300 mg single, oral
dose: 300 mg
route of administration: Oral
experiment type: SINGLE
co-administered: DYPHYLLINE
PROXYPHYLLINE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: UNKNOWN
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
100%
PROXYPHYLLINE plasma
Homo sapiens
Doses

Doses

DosePopulationAdverse events​
100 mg 3 times / day multiple, oral
Recommended
Dose: 100 mg, 3 times / day
Route: oral
Route: multiple
Dose: 100 mg, 3 times / day
Sources:
unhealthy, UNKNOWN
Health Status: unhealthy
Age Group: UNKNOWN
Sex: M+F
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
Synthesis, pharmacological activity and nitric oxide generation by nitrate derivatives of theophylline.
2008-05
Modifying the release of proxyphylline from PVA hydrogels using surface crosslinking.
2008-02-12
Surface crosslinking for delayed release of proxyphylline from PHEMA hydrogels.
2008-02-12
Hydrophilic molecularly imprinted poly(hydroxyethyl-methacrylate) polymers.
2006-07
The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis.
2004-04-22
Minimization of initial burst in poly(vinyl alcohol) hydrogels by surface extraction and surface-preferential crosslinking.
2002-11-06
Polymer particle erosion controlling drug release. II. Swelling investigations to clarify the release mechanism.
2002-10-24
Kinetic-spectrophotometric determination of theophylline, dyphylline, and proxyphylline by use of partial least-squares regression.
2002-09
Application of micellar electrokinetic chromatography to the quality control of a pharmaceutical preparation containing three bronchodilators.
2002-02
Antianaphylactic and antiasthmatic properties of new piperazinyl 7-(beta-hydroxypropyl)-theophylline derivatives in guinea pigs.
2002-01-15
Multi-component kinetic-spectrophotometric analysis. Selection of wavelength and time ranges.
2001-07
[Effectiveness of proxyphylline in chronic obstructive pulmonary disease (author's transl)].
1980-06-20
Patents

Patents

Sample Use Guides

In Vivo Use Guide
intravenous: 29 mumol/kgsingle oral: 21 mumol/kg and multiple oral: 21 mumol/kg three times a day
Route of Administration: Other
In Vitro Use Guide
Inhibition of cAMP and cGMP hydrolysis in human lung tissue by proxyphylline and its main metabolite 1-methyl-7-(beta-hydroxypropyl)xanthine was compared with theophylline and its metabolite 3-methylxanthine. The Inhibition constant of proxyphylline was 0.06-0.7 mmol/l at low cAMP concentrations and at low and high cGMP concentrations, while it was 1.0 mmol/l at high cAMP concentrations
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:21:20 GMT 2025
Edited
by admin
on Mon Mar 31 18:21:20 GMT 2025
Record UNII
13G1DMN4P0
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MONOPHYLLIN
Preferred Name English
PROXYPHYLLINE
EP   INN   JAN   MART.   MI   WHO-DD  
INN  
Official Name English
SPASMOLYSIN
Brand Name English
THEAN
Brand Name English
7 BETA-HYDROXYPROPYL THEOPHYLLINE
Systematic Name English
proxyphylline [INN]
Common Name English
SIGOPHYL
Brand Name English
1H-PURINE-2,6-DIONE, 3,7-DIHYDRO-7-(2-HYDROXYPROPYL)-1,3-DIMETHYL-
Systematic Name English
7-.BETA.-HYDROXYPROPYL THEOPHYLLINE
Systematic Name English
THEODEN
Brand Name English
SPANTIN
Brand Name English
PROXYPHYLLINE [JAN]
Common Name English
DIPROPHYLLINE IMPURITY D [EP IMPURITY]
Common Name English
(±)-PROXYPHYLLIN
Common Name English
R03DA03
Code English
Proxyphylline [WHO-DD]
Common Name English
PUROPHYLLIN
Common Name English
PROXYPHYLLINE [EP MONOGRAPH]
Common Name English
7-(2-HYDROXYPROPYL)THEOPHYLLINE
Systematic Name English
OXYPROPYLTHEOPHYLLINE
Common Name English
PROXYPHYLLINE [MART.]
Common Name English
NSC-163343
Code English
.BETA.-HYDROXYPROPYLTHEOPHYLLINE
Systematic Name English
BRONTYL
Brand Name English
PROXYPHYLLINE [MI]
Common Name English
1,3-DIMETHYL-7-(2-HYDROXYPROPYL)XANTHINE
Systematic Name English
Classification Tree Code System Code
WHO-ATC R03DA03
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
WHO-VATC QR03DB03
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
WHO-VATC QR03DA03
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
WHO-ATC R03DB03
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
NCI_THESAURUS C319
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
NCI_THESAURUS C744
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
Code System Code Type Description
CAS
86480-51-5
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
SUPERSEDED
ECHA (EC/EINECS)
210-028-7
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
NCI_THESAURUS
C80339
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
ChEMBL
CHEMBL37390
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
RXCUI
34906
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY RxNorm
MERCK INDEX
m9284
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY Merck Index
WIKIPEDIA
PROXYPHYLLINE
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
EVMPD
SUB10153MIG
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
PUBCHEM
4977
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
MESH
C003237
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
DRUG BANK
DB13449
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
INN
969
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
NSC
163343
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
SMS_ID
100000080861
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
CAS
603-00-9
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
EPA CompTox
DTXSID5023536
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
FDA UNII
13G1DMN4P0
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
DRUG CENTRAL
2323
Created by admin on Mon Mar 31 18:21:20 GMT 2025 , Edited by admin on Mon Mar 31 18:21:20 GMT 2025
PRIMARY
Related Record Type Details
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY